Comprehensive genomic characterization defines human glioblastoma genes and core pathways

Cited by (182)

Items 101–182 of 182

1. Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell–driven rejection of high-grade glioma
   Garg, Abhishek D., Vandenberk, Lien, Koks, Carolien, Verschuere, Tina, Boon, Louis, Van Gool, Stefaan W., Agostinis, Patrizia · 2016 · Science Translational Medicine
2. Exploiting cancer cell vulnerabilities to develop a combination therapy for ras-driven tumors
   De Raedt, Thomas, Walton, Zandra, Yecies, Jessica L., Li, Danan, Chen, Yimei, Malone, Clare F., Maertens, Ophélia, Jeong, Seung Min, Bronson, Roderick T., Lebleu, Valerie et al. · 2011 · Cancer Cell
3. Inhibition of SHP2-mediated dephosphorylation of Ras suppresses oncogenesis
   Bunda, Severa, Burrell, Kelly, Heir, Pardeep, Zeng, Lifan, Alamsahebpour, Amir, Kano, Yoshihito, Raught, Brian, Zhang, Zhong-Yin, Zadeh, Gelareh, Ohh, Michael · 2015 · Nature Communications
4. The genetic and neurobiologic compass points toward common signaling dysfunctions in autism spectrum disorders
   Levitt, Pat, Campbell, Daniel B. · 2009 · Journal of Clinical Investigation
5. Novel Oncogenic <i>PDGFRA</i> Mutations in Pediatric High-Grade Gliomas
   Paugh, Barbara S., Zhu, Xiaoyan, Qu, Chunxu, Endersby, Raelene, Diaz, Alexander K., Zhang, Junyuan, Bax, Dorine A., Carvalho, Diana, Reis, Rui M., Onar-Thomas, Arzu et al. · 2013 · Cancer Research
6. Pattern of retinoblastoma pathway inactivation dictates response to CDK4/6 inhibition in GBM
   Wiedemeyer, W. Ruprecht, Dunn, Ian F., Quayle, Steven N., Zhang, Jianhua, Chheda, Milan G., Dunn, Gavin P., Zhuang, Li, Rosenbluh, Joseph, Chen, Shujuan, Xiao, Yonghong et al. · 2010 · Proceedings of the National Academy of Sciences
7. Establishment, maintenance and in vitro and in vivo applications of primary human glioblastoma multiforme (GBM) xenograft models for translational biology studies and drug discovery
   Carlson, Brett L., Pokorny, Jenny L., Schroeder, Mark A., Sarkaria, Jann N. · 2011 · Current Protocols in Pharmacology
8. Molecular and Genomic Alterations in Glioblastoma Multiforme
   Crespo, Ines, Vital, Ana Louisa, Gonzalez-Tablas, María, Patino, María del Carmen, Otero, Alvaro, Lopes, María Celeste, de Oliveira, Catarina, Domingues, Patricia, Orfao, Alberto, Tabernero, Maria Dolores · 2015 · The American Journal of Pathology
9. Systems cancer medicine: towards realization of predictive, preventive, personalized and participatory (P4) medicine
   Tian, Q., Price, N. D., Hood, L. · 2012 · Journal of Internal Medicine
10. HGF/c-MET pathway in cancer: from molecular characterization to clinical evidence
    Fu, Jianjiang, Su, Xiaorui, Li, Zhihua, Deng, Ling, Liu, Xiawei, Feng, Xuancheng, Peng, Juan · 2021 · Oncogene
11. Characterizing DNA methylation alterations from The Cancer Genome Atlas
    Weisenberger, Daniel J. · 2014 · Journal of Clinical Investigation
12. Identification of Causal Genetic Drivers of Human Disease through Systems-Level Analysis of Regulatory Networks
    Chen, James C., Alvarez, Mariano J., Talos, Flaminia, Dhruv, Harshil, Rieckhof, Gabrielle E., Iyer, Archana, Diefes, Kristin L., Aldape, Kenneth, Berens, Michael, Shen, Michael M. et al. · 2014 · Cell
13. Targetable Signaling Pathway Mutations Are Associated with Malignant Phenotype in <i>IDH</i> -Mutant Gliomas
    Wakimoto, Hiroaki, Tanaka, Shota, Curry, William T., Loebel, Franziska, Zhao, Dan, Tateishi, Kensuke, Chen, Juxiang, Klofas, Lindsay K., Lelic, Nina, Kim, James C. et al. · 2014 · Clinical Cancer Research
14. Multifarious functions of PDGFs and PDGFRs in tumor growth and metastasis
    Cao, Yihai · 2013 · Trends in Molecular Medicine
15. RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls
    Noerholm, Mikkel, Balaj, Leonora, Limperg, Tobias, Salehi, Afshin, Zhu, Lin Dan, Hochberg, Fred H, Breakefield, Xandra O, Carter, Bob S, Skog, Johan · 2012 · BMC Cancer
16. Evolution of the cancer genome
    Podlaha, Ondrej, Riester, Markus, De, Subhajyoti, Michor, Franziska · 2012 · Trends in Genetics
17. Epigenetic mechanisms in glioblastoma multiforme
    Nagarajan, Raman P., Costello, Joseph F. · 2009 · Seminars in Cancer Biology
18. Review of applications of high-throughput sequencing in personalized medicine: barriers and facilitators of future progress in research and clinical application
    Lightbody, Gaye, Haberland, Valeriia, Browne, Fiona, Taggart, Laura, Zheng, Huiru, Parkes, Eileen, Blayney, Jaine K · 2019 · Briefings in Bioinformatics
19. Current understanding of the role and targeting of tumor suppressor p53 in glioblastoma multiforme
    England, Bryant, Huang, Tiangui, Karsy, Michael · 2013 · Tumor Biology
20. Myc-Driven glycolysis is a therapeutic target in glioblastoma
    Tateishi, Kensuke, Iafrate, A. John, Ho, Quan, Curry, William T., Batchelor, Tracy T., Flaherty, Keith T., Onozato, Maristela L., Lelic, Nina, Sundaram, Sudhandra, Cahill, Daniel P. et al. · 2016 · Clinical Cancer Research
21. Discovery of SHP2-D26 as a First, Potent, and Effective PROTAC Degrader of SHP2 Protein
    Wang, Mingliang, Lu, Jianfeng, Wang, Mi, Yang, Chao-Yie, Wang, Shaomeng · 2020 · Journal of Medicinal Chemistry
22. Omics and Drug Response
    Meyer, Urs A., Zanger, Ulrich M., Schwab, Matthias · 2013 · Annual Review of Pharmacology and Toxicology
23. Combining multidimensional genomic measurements for predicting cancer prognosis: observations from TCGA
    Zhao, Q., Shi, X., Xie, Y., Huang, J., Shia, B., Ma, S. · 2015 · Briefings in Bioinformatics
24. Applications of Genome-Scale Metabolic Models in Biotechnology and Systems Medicine
    Zhang, Cheng, Hua, Qiang · 2016 · Frontiers in Physiology
25. Beginnings of Artificial Intelligence in Medicine (AIM): Computational Artifice Assisting Scientific Inquiry and Clinical Art – with Reflections on Present AIM Challenges
    Kulikowski, Casimir A. · 2019 · Yearbook of Medical Informatics
26. Collateral lethality: a new therapeutic strategy in oncology
    Muller, Florian L., Aquilanti, Elisa A., DePinho, Ronald A. · 2015 · Trends in Cancer
27. Characterizing the genetic basis of methylome diversity in histologically normal human lung tissue
    Shi, Jianxin, Marconett, Crystal N., Duan, Jubao, Hyland, Paula L., Li, Peng, Wang, Zhaoming, Wheeler, William, Zhou, Beiyun, Campan, Mihaela, Lee, Diane S. et al. · 2014 · Nature Communications
28. ZFHX4 Interacts with the NuRD Core Member CHD4 and Regulates the Glioblastoma Tumor-Initiating Cell State
    Chudnovsky, Yakov, Kim, Dohoon, Zheng, Siyuan, Whyte, Warren A., Bansal, Mukesh, Bray, Mark-Anthony, Gopal, Shuba, Theisen, Matthew A., Bilodeau, Steve, Thiru, Prathapan et al. · 2014 · Cell Reports
29. Multidimensional scaling of diffuse gliomas: Application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery
    Cimino, Patrick J., Zager, Michael, McFerrin, Lisa, Wirsching, Hans-Georg, Bolouri, Hamid, Hentschel, Bettina, von Deimling, Andreas, Jones, David, Reifenberger, Guido, Weller, Michael et al. · 2017 · Acta Neuropathologica Communications
30. DINGO: differential network analysis in genomics
    Ha, Min Jin, Baladandayuthapani, Veerabhadran, Do, Kim-Anh · 2015 · Bioinformatics
31. Complex DNA repair pathways as possible therapeutic targets to overcome temozolomide resistance in glioblastoma
    Yoshimoto, Koji, Mizoguchi, Masahiro, Hata, Nobuhiro, Murata, Hideki, Hatae, Ryusuke, Amano, Toshiyuki, Nakamizo, Akira, Sasaki, Tomio · 2012 · Frontiers in Oncology
32. Integrative phenotyping framework (iPF): integrative clustering of multiple omics data identifies novel lung disease subphenotypes
    Kim, SungHwan, Herazo-Maya, Jose D., Kang, Dongwan D., Juan-Guardela, Brenda M., Tedrow, John, Martinez, Fernando J., Sciurba, Frank C., Tseng, George C., Kaminski, Naftali · 2015 · BMC Genomics
33. Clinical Cancer Advances 2009: Major Research Advances in Cancer Treatment, Prevention, and Screening—A Report From the American Society of Clinical Oncology
    Petrelli, Nicholas J., Winer, Eric P., Brahmer, Julie, Dubey, Sarita, Smith, Sonali, Thomas, Charles, Vahdat, Linda T., Obel, Jennifer, Vogelzang, Nicholas, Markman, Maurie et al. · 2009 · Journal of Clinical Oncology
34. Preclinical Efficacy of the MDM2 Inhibitor RG7112 in <i>MDM2</i> -Amplified and <i>TP53</i> Wild-type Glioblastomas
    Verreault, Maite, Schmitt, Charlotte, Goldwirt, Lauriane, Pelton, Kristine, Haidar, Samer, Levasseur, Camille, Guehennec, Jeremy, Knoff, David, Labussière, Marianne, Marie, Yannick et al. · 2016 · Clinical Cancer Research
35. Portrait of a cancer: mutational signature analyses for cancer diagnostics
    Van Hoeck, Arne, Tjoonk, Niels H., van Boxtel, Ruben, Cuppen, Edwin · 2019 · BMC Cancer
36. A comprehensive review of SHP2 and its role in cancer
    Asmamaw, Moges Dessale, Shi, Xiao-Jing, Zhang, Li-Rong, Liu, Hong-Min · 2022 · Cellular Oncology
37. The chaperones Hsp90 and Cdc37 mediate the maturation and stabilization of protein kinase C through a conserved PXXP motif in the C-terminal tail.
    Gould, Christine M., Kannan, Natarajan, Taylor, Susan S., Newton, Alexandra C. · 2009 · Journal of Biological Chemistry
38. A20 Ubiquitin Ligase–Mediated Polyubiquitination of RIP1 Inhibits Caspase-8 Cleavage and TRAIL-Induced Apoptosis in Glioblastoma
    Bellail, Anita C., Olson, Jeffrey J., Yang, Xiaolu, Chen, Zhijian J., Hao, Chunhai · 2012 · Cancer Discovery
39. p120-catenin-dependent collective brain infiltration by glioma cell networks
    Gritsenko, Pavlo G., Atlasy, Nader, Dieteren, Cindy E. J., Navis, Anna C., Venhuizen, Jan-Hendrik, Veelken, Cornelia, Schubert, Dirk, Acker-Palmer, Amparo, Westerman, Bart A., Wurdinger, Thomas et al. · 2020 · Nature Cell Biology
40. Integrating genetic and gene expression evidence into genome-wide association analysis of gene sets
    Xiong, Qing, Ancona, Nicola, Hauser, Elizabeth R., Mukherjee, Sayan, Furey, Terrence S. · 2012 · Genome Research
41. Integrative multi-omics module network inference with lemon-tree
    Bonnet, Eric, Calzone, Laurence, Michoel, Tom · 2015 · PLoS Computational Biology
42. Radiologically Defined Ecological Dynamics and Clinical Outcomes in Glioblastoma Multiforme: Preliminary Results
    Zhou, Mu, Hall, Lawrence, Goldgof, Dmitry, Russo, Robin, Balagurunathan, Yoganand, Gillies, Robert, Gatenby, Robert · 2014 · Translational Oncology
43. A GATA4-regulated tumor suppressor network represses formation of malignant human astrocytomas
    Agnihotri, Sameer, Wolf, Amparo, Munoz, Diana M., Smith, Christopher J., Gajadhar, Aaron, Restrepo, Andres, Clarke, Ian D., Fuller, Gregory N., Kesari, Santosh, Dirks, Peter B. et al. · 2011 · Journal of Experimental Medicine
44. Chromatin Remodeling Defects in Pediatric and Young Adult Glioblastoma: A Tale of a Variant <scp>H</scp>istone 3 Tail
    Fontebasso, Adam M., Liu, Xiao‐Yang, Sturm, Dominik, Jabado, Nada · 2013 · Brain Pathology
45. Mirsynergy: detecting synergistic miRNA regulatory modules by overlapping neighbourhood expansion
    Li, Yue, Liang, Cheng, Wong, Ka-Chun, Luo, Jiawei, Zhang, Zhaolei · 2014 · Bioinformatics
46. Copy number variations and cancer susceptibility
    Shlien, Adam, Malkin, David · 2010 · Current Opinion in Oncology · Retracted
47. MicroRNA-21 silencing enhances the cytotoxic effect of the antiangiogenic drug sunitinib in glioblastoma
    Costa, Pedro M., Cardoso, Ana L., Nóbrega, Clévio, Pereira de Almeida, Luís F., Bruce, Jeffrey N., Canoll, Peter, Pedroso de Lima, Maria C. · 2013 · Human Molecular Genetics
48. Histone deacetylase inhibitors exert anti-tumor effects on human adherent and stem-like glioma cells
    Was, Halina, Krol, Sylwia K., Rotili, Dante, Mai, Antonello, Wojtas, Bartosz, Kaminska, Bozena, Maleszewska, Marta · 2019 · Clinical Epigenetics
49. Individualized patient tumor organoids faithfully preserve human brain tumor ecosystems and predict patient response to therapy
    Peng, Tianping, Ma, Xiujian, Hua, Wei, Wang, Changwen, Chu, Youjun, Sun, Meng, Fermi, Valentina, Hamelmann, Stefan, Lindner, Katharina, Shao, Chunxuan et al. · 2025 · Cell Stem Cell
50. Neutralization of terminal differentiation in gliomagenesis
    Hu, Jian, Ho, Allen L., Yuan, Liang, Hu, Baoli, Hua, Sujun, Hwang, Soyoon Sarah, Zhang, Jianhua, Hu, Tianyi, Zheng, Hongwu, Gan, Boyi et al. · 2013 · Proceedings of the National Academy of Sciences
51. Intratumoral Patterns of Genomic Imbalance in Glioblastomas
    Nobusawa, Sumihito, Lachuer, Joel, Wierinckx, Anne, Kim, Young Ho, Huang, Jian, Legras, Catherine, Kleihues, Paul, Ohgaki, Hiroko · 2010 · Brain Pathology
52. Mechanism and therapeutic potential of tumor-immune symbiosis in glioblastoma
    Pang, Lizhi, Khan, Fatima, Heimberger, Amy B., Chen, Peiwen · 2022 · Trends in Cancer
53. A highly potent CDK4/6 inhibitor was rationally designed to overcome blood brain barrier in gliobastoma therapy
    Yin, Lei, Li, Heng, Liu, Wenjian, Yao, Zhenglin, Cheng, Zhenzhen, Zhang, Huabei, Zou, Hui · 2018 · European Journal of Medicinal Chemistry
54. Targeting miR-21 in glioma: a small RNA with big potential
    Moore, Lynette M, Zhang, Wei · 2010 · Expert Opinion on Therapeutic Targets
55. Combination therapy in a xenograft model of glioblastoma: Enhancement of the antitumor activity of temozolomide by an MDM2 antagonist
    Wang, Haiyan, Cai, Shanbao, Bailey, Barbara J., Reza Saadatzadeh, M., Ding, Jixin, Tonsing-Carter, Eva, Georgiadis, Taxiarchis M., Zachary Gunter, T., Long, Eric C., Minto, Robert E. et al. · 2017 · Journal of Neurosurgery
56. Protection of the human gene research literature from contract cheating organizations known as research paper mills
    Byrne, Jennifer A, Park, Yasunori, Richardson, Reese A K, Pathmendra, Pranujan, Sun, Mengyi, Stoeger, Thomas · 2022 · Nucleic Acids Research
57. Comprehensive pharmacogenomic characterization of gastric cancer
    Sa, Jason K., Hong, Jung Yong, Lee, In-Kyoung, Kim, Ju-sun, Sim, Moon-Hee, Kim, Ha Jung, An, Ji Yeong, Sohn, Tae Sung, Lee, Joon Ho, Bae, Jae Moon et al. · 2020 · Genome Medicine
58. Nervous system regulation of the cancer genome
    Cole, Steven W. · 2013 · Brain, Behavior, and Immunity
59. Efficacy of the MDM2 inhibitor SAR405838 in glioblastoma is limited by poor distribution across the blood-brain barrier
    Kim, Minjee, Ma, Daniel J., Calligaris, David, Zhang, Shuangling, Feathers, Ryan W., Vaubel, Rachael A., Meaux, Isabelle, Mladek, Ann C., Parrish, Karen E., Jin, Fang et al. · 2018 · Molecular Cancer Therapeutics
60. MiR-338-3p regulates neuronal maturation and suppresses glioblastoma proliferation.
    Howe, James R., Li, Emily S., Streeter, Sarah E., Rahme, Gilbert J., Chipumuro, Edmond, Russo, Grace B., Litzky, Julia F., Hills, L. Benjamin, Rodgers, Kyla R., Skelton, Patrick D. et al. · 2017 · PLoS ONE
61. MDM2/X inhibitors as radiosensitizers for glioblastoma targeted therapy
    Miles, Xanthene, Vandevoorde, Charlot, Hunter, Alistair, Bolcaen, Julie · 2021 · Frontiers in Oncology
62. New structural and functional insight into the regulation of Ras
    Kano, Yoshihito, Cook, Jonathan D., Lee, Jeffrey E., Ohh, Michael · 2016 · Seminars in Cell &amp; Developmental Biology
63. GSVD Comparison of Patient-Matched Normal and Tumor aCGH Profiles Reveals Global Copy-Number Alterations Predicting Glioblastoma Multiforme Survival
    Lee, Cheng H., Alpert, Benjamin O., Sankaranarayanan, Preethi, Alter, Orly · 2012 · PLoS ONE
64. BI-907828, a novel potent MDM2 inhibitor, inhibits glioblastoma brain tumor stem cells in vitro and prolongs survival in orthotopic xenograft mouse models
    Hao, Xiaoguang, Bahia, Ravinder K, Cseh, Orsolya, Bozek, Danielle A, Blake, Sophia, Rinnenthal, Jörg, Weyer-Czernilofsky, Ulrike, Rudolph, Dorothea, Artee Luchman, H · 2023 · Neuro-Oncology
65. Actin cytoskeleton organization, cell surface modification and invasion rate of 5 glioblastoma cell lines differing in PTEN and p53 status
    Djuzenova, Cholpon S., Fiedler, Vanessa, Memmel, Simon, Katzer, Astrid, Hartmann, Susanne, Krohne, Georg, Zimmermann, Heiko, Scholz, Claus-Jürgen, Polat, Bülent, Flentje, Michael et al. · 2015 · Experimental Cell Research
66. Caregiver burden by treatment and clinical characteristics of patients with glioblastoma
    Au, Trang H., Willis, Connor, Reblin, Maija, Peters, Katherine B., Nghiemphu, Phioanh Leia, Taylor, Jennie W., Colman, Howard, Cohen, Adam L., Ormond, D. Ryan, Chakravarti, Arnab et al. · 2022 · Supportive Care in Cancer
67. Prioritizing cancer-related key miRNA-target interactions by integrative genomics
    Xiao, Yun, Guan, Jinxia, Ping, Yanyan, Xu, Chaohan, Huang, Teng, Zhao, Hongying, Fan, Huihui, Li, Yiqun, Lv, Yanling, Zhao, Tingting et al. · 2012 · Nucleic Acids Research
68. Nonredundant, isoform-specific roles of HDAC1 in glioma stem cells
    Lo Cascio, Costanza, McNamara, James B., Melendez, Ernesto L., Lewis, Erika M., Dufault, Matthew E., Sanai, Nader, Plaisier, Christopher L., Mehta, Shwetal · 2021 · JCI Insight
69. Comparative analysis of algorithms for integration of copy number and expression data
    Louhimo, Riku, Lepikhova, Tatiana, Monni, Outi, Hautaniemi, Sampsa · 2012 · Nature Methods
70. Immunotherapy in Glioblastoma: A Clinical Perspective
    Desbaillets, Nicolas, Hottinger, Andreas Felix · 2021 · Cancers
71. MDM2 inhibition in the treatment of glioblastoma: From concept to clinical investigation
    Pellot Ortiz, Karolina I., Rechberger, Julian S., Nonnenbroich, Leo F., Daniels, David J., Sarkaria, Jann N. · 2023 · Biomedicines
72. Expression of genes that control core fucosylation in hepatocellular carcinoma: Systematic review
    Norton, Pamela A, Mehta, Anand S · 2019 · World Journal of Gastroenterology
73. MONET: Multi-omic module discovery by omic selection
    Rappoport, Nimrod, Safra, Roy, Shamir, Ron · 2020 · PLoS Computational Biology
74. Sox21 inhibits glioma progression<i>in vivo</i>by forming complexes with Sox2 and stimulating aberrant differentiation
    Caglayan, Demet, Lundin, Erika, Kastemar, Marianne, Westermark, Bengt, Ferletta, Maria · 2013 · International Journal of Cancer
75. Challenges and Promise for Glioblastoma Treatment through Extracellular Vesicle Inquiry
    Liguori, Giovanna L. · 2024 · Cells
76. Integrated genomic analyses of ovarian carcinoma
    The Cancer Genome Atlas Research Network · 2011 · Nature
77. ADAMTS12 acts as a tumor microenvironment related cancer promoter in gastric cancer
    Hou, Yangming, Xu, Yingjuan, Wu, Dequan · 2021 · Scientific Reports
78. Human epidermal growth factor receptor 4 (Her4) Suppresses p53 Protein via Targeting the MDMX-MDM2 Protein Complex
    Gerarduzzi, Casimiro, de Polo, Anna, Liu, Xue-Song, El Kharbili, Manale, Little, John B., Yuan, Zhi-Min · 2016 · Journal of Biological Chemistry
79. Tracing unknown tumor origins with a biological-pathway-based transformer model
    Xie, Jiajing, Chen, Ying, Luo, Shijie, Yang, Wenxian, Lin, Yuxiang, Wang, Liansheng, Ding, Xin, Tong, Mengsha, Yu, Rongshan · 2024 · Cell Reports Methods
80. Dynamic visualization of multi-level molecular data: The Director package in R
    Icay, Katherine, Liu, Chengyu, Hautaniemi, Sampsa · 2018 · Computer Methods and Programs in Biomedicine
81. Resistance Mechanisms to Cyclin-Dependent Kinase Inhibitors
    Wiedemeyer, Wolf Ruprecht · 2018 · Resistance to Targeted Anti-Cancer Therapeutics
82. Targeting eIF4A-dependent translation in genetically complex sarcoma
    Kim, Young-Mi, Mohan, Prathibha, Sehrawat, Urmila, Seffar, Evan, De Queiroz, Rafaela Muniz, Chadalavada, Kalyani, Persaud, Nikita, Okada, Tomoyo, Kulkarni, Anirudh, Lin, Jianan et al. · 2026 · JCI Insight